Starling Oncology, Inc.

STLN Healthcare Medical Care Facilities

Starling Oncology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $502.7 million, up 27.8% from fiscal 2024. In the quarter to June 2026, revenue grew 34.6%, EPS grew 46.7%, free cash flow grew 196.7% and total debt rose 6.46%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

6.43 0.48 −6.95%
Market cap
$690.9M
P/E
0.0×
Fwd P/E
−32.5×
Dividend yield
—
F-score
4/9
Altman Z
1.42
Beneish M
−3.39
Dividend safety
n/a
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — 3 2 3 4
P/E ratio
— — 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — 11.54 4.45 0.58 0.57 (0.08) 1.42
P/S ratio
— — 0.00 3.18 0.46 0.52 0.06 0.65
P/FCF ratio
— — 1,256.84 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— — (2.54) 2.58 0.57 (0.95) (4.01) (5.27)
Beneish M-Score
— — — (1.89) (0.91) (3.63) (3.24) (3.39)
P/Operating CF
— — 632.84 (27.67) (8.37) (43.57) 5.56 101.73
P/B ratio
— — 22.72 6.20 0.95 2.97 6.48 0.00
Price to Tangible BV
— — 0.00 10.89 1.40 5.32 0.00 0.00
EV/Sales
— — 0.00 2.65 0.49 0.54 0.17 0.74
EV/EBITDA
— — 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
— — 1,268.51 (16.44) (2.01) (4.79) (2.52) (15.17)
EV/FCF
— — 1,268.51 (15.12) (1.85) (4.25) (2.21) (13.42)
Quick Ratio
— 0.92 0.81 4.58 3.84 3.62 1.88 1.31
Current Ratio
— 0.92 1.04 5.17 4.39 4.12 2.15 1.59
Net Debt/EBITDA
— 10.87 (1.20) 2.71 (0.10) (0.08) (0.90) (2.11)
Debt/Assets
0.00% 0.00% 18.16% 0.09% 30.81% 41.50% 53.92% 47.01%
Debt/Equity
— 0.00 0.42 0.00 0.65 1.52 25.95 (4.92)
Asset Turnover
— 0.00 5.70 1.51 1.09 1.38 2.06 2.98
Operating CF/Net income
— 0.00 (0.04) 2.99 (406.29) 0.44 0.41 0.41
Capex/Depreciation
— — (0.37) (0.90) (0.35) (0.17) (0.31) (0.21)
Interest Coverage
— — (23.62) (143.31) (20.08) (11.36) (8.02) (3.20)
ROE
— (0.02%) (101.85%) (16.52%) 0.13% (92.20%) (213.36%) 999.19%
ROA
— (9.20%) (43.57%) (8.12%) 0.07% (35.28%) (33.86%) (35.93%)
ROIC
— 0.00% (15.05%) 0.00% (39.40%) (78.92%) (79.86%) (80.21%)
Return on Tangible Assets
— 100.00% (445.20%) (8.51%) 0.14% (69.46%) (89.70%) (115.51%)
Average Days of Receivables
— — 33.59 38.20 58.45 48.31 45.17 43.07
Research and Development Expense of Revenue
— — 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
— 0.00% 22.34% 41.07% 47.40% 35.11% 27.41% 21.00%
Intangible Assets out of Total Assets
0.00 0.00 0.51 0.22 0.15 0.12 0.13 0.11
Share Based Compensation of Revenue
— — 0.08% 12.09% 10.96% 5.49% 2.83% 0.91%
Graham Net Nets
— — (0.01) 0.08 (0.07) (0.05) (2.44) (0.21)
Graham Number
— — 0.00 0.00 0.00 0.00 0.00 1.46
Earnings Yield
— — (2.24%) (1.67%) (1.20%) (40.00%) (229.03%) (15.73%)
Free Cash Flow Yield
— — 0.08% (5.50%) (57.41%) (24.10%) (130.36%) (8.45%)
Revenue per Share
— 0.00 3.17 3.07 3.47 4.40 5.24 5.44
Operating CF per Share
— 0.00 0.01 (0.49) (0.85) (0.49) (0.35) (0.27)
Capex per Share
— 0.00 (0.02) (0.05) (0.08) (0.06) (0.05) (0.03)
Free Cash Flow per Share
— 0.00 (0.01) (0.54) (0.92) (0.55) (0.40) (0.30)
Cash per Share
— 0.01 0.10 1.74 1.01 1.12 0.66 0.36
Shareholders Equity per Share
— 0.00 0.48 1.57 1.69 0.77 0.05 (0.17)
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 0.00 0.48 1.57 1.69 0.77 0.05 (0.17)
Free Cash Flow
— — (0.69) (35.73) (67.28) (40.88) (30.33) (27.79)
Working Capital
— 0.00 1.11 124.26 100.70 108.71 60.20 41.79
Capital Expenditures
— — (1.19) (3.05) (5.53) (4.57) (3.79) (3.20)
Net Current Asset Value
— 0.00 (7.87) 54.78 (8.07) (8.72) (56.71) (67.63)
EV/EBIT
— — 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
— — 0.01 0.02 0.02 0.01 0.01 0.01
Price to Operating Income
— — 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
— — 1.54 0.81 1.85 2.42 1.02 1.43
Cash ROIC
— 0.00% (1.49%) (16.28%) (24.24%) (18.03%) (20.72%) (29.17%)
Accounts Receivable Turnover
— — 9.74 10.54 8.19 7.78 8.59 9.31
Accounts Payable Turnover
— — 10.68 11.50 16.08 22.24 17.52 12.63
Inventory Turnover
— — 27.92 30.05 25.53 23.08 28.62 31.68
Average Days of Payables
— — 30.63 35.02 17.07 19.90 26.16 36.96
Days of Inventory on Hand
— — 10.55 14.49 16.87 18.86 10.80 14.45
Average Receivables
— — 19.25 19.25 30.84 41.67 45.80 54.00
Average Payables
— — 14.10 14.10 12.47 11.90 19.38 33.75
Average Inventory
— — 5.40 5.40 7.85 11.47 11.86 13.46
Average Assets
— 0.03 32.87 134.56 232.55 235.45 190.98 168.69
Average Common Equity
— 14.06 14.06 66.13 113.67 90.10 30.31 (6.07)

Fold the line items

Columns are period end dates